Clinical burden of venous thromboembolism

Abstract

Even among high-risk groups it is not possible to identify individuals who will go on to develop VTE, and, therefore, thromboprophylaxis is a recommended component of the management of high-risk patients. Ensuring patients receive safe, effective, easily administered antithrombotic therapy both in hospital and post-discharge, for a sufficient length of time, should be central to any strategy to reduce incident or recurrent VTE and minimise the risk of long-term complications.

Association Between Inpatient Surveillance and Venous Thromboembolism Rates After Hospital Discharge

“…6,7 In addition, the 1-year financial burden of treating the complications associated with VTE has been estimated at $33 000. 8 Studies 9,10 support the notion that appropriate prophylaxis can reduce the incidence of postoperative VTE.…”

Incidence of Deep Vein Thrombosis and Pulmonary Embolus Following Periacetabular Osteotomy

“…Complications associated with venous thromboembolism include recurrent venous thromboembolism, post-thrombotic syndrome, chronic pulmonary hypertension, wound drainage, infection, and death 3 . Awareness of the patient risk of and appropriate prophylaxis for venous thromboembolism is accepted as standard practice in contemporary orthopaedic surgery [3][4][5] . Ideally, prophylaxis for venous thromboembolism minimizes the risk of developing venous thrombosis and pulmonary embolus without increasing anesthetic risks, bleeding complications, or hematoma formation.…”

COPD and risk of venous thromboembolism and mortality in a general population

“…Venous thromboembolism (VTE), a collective term for deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common disease with complications such as the post-thrombotic syndrome, chronic thromboembolic pulmonary hypertension and death [4,5]. COPD is considered a moderate risk factor of VTE [6].…”